WASHINGTON — Among adults with atherosclerotic CVD and impaired kidney function, residual inflammation is a stronger predictor of recurrent CV events than hyperlipidemia, particularly for CV and all-cause mortality, researchers reported.New data from a secondary analysis of the CANTOS trial may have clinical implications for the CV risk stratification of people with chronic kidney disease
Inflammation in CKD is an issue to measure and address